Arcturus Therapeutics Holdings (ARCT) Interest & Investment Income (2018)

Arcturus Therapeutics Holdings (ARCT) posted Interest & Investment Income of -$4000.0 for Q4 2018, down 300.0% on a QoQ basis from $2000.0 in Q3 2018.

Arcturus Therapeutics Holdings (ARCT) Interest & Investment Income (2018) Analysis & Trends

Arcturus Therapeutics Holdings' Interest & Investment Income history runs 1 years deep, the most recent figure standing at -$4000.0 for Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Arcturus Therapeutics Holdings 165.13 Mn -46.25 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 -4,000.00
Sep 30, 2018 2,000.00
Jun 30, 2018 7,000.00